| Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development MA Zocco, E Di Stasio, R De Cristofaro, M Novi, ME Ainora, F Ponziani, ... Journal of hepatology 51 (4), 682-689, 2009 | 592 | 2009 |
| Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules E Terzi, M Iavarone, M Pompili, L Veronese, G Cabibbo, M Fraquelli, ... Journal of hepatology 68 (3), 485-492, 2018 | 220 | 2018 |
| Intestinal permeability in cirrhotic patients with and without spontaneous bacterial peritonitis: is the ring closed? E Scarpellini, V Valenza, M Gabrielli, EC Lauritano, G Perotti, G Merra, ... Official journal of the American College of Gastroenterology| ACG 105 (2 …, 2010 | 150 | 2010 |
| Impact of Lactobacillus reuteri Supplementation on Anti‐Helicobacter pylori Levofloxacin‐Based Second‐Line Therapy V Ojetti, G Bruno, ME Ainora, G Gigante, G Rizzo, D Roccarina, ... Gastroenterology research and practice 2012 (1), 740381, 2012 | 146 | 2012 |
| Bacteroides thetaiotaomicron in the gut: molecular aspects of their interaction MA Zocco, ME Ainora, G Gasbarrini, A Gasbarrini Digestive and Liver Disease 39 (8), 707-712, 2007 | 129 | 2007 |
| Incidence of deep vein thrombosis among non‐ICU patients hospitalized for COVID‐19 despite pharmacological thromboprophylaxis A Santoliquido, A Porfidia, A Nesci, G De Matteis, G Marrone, E Porceddu, ... Journal of Thrombosis and Haemostasis 18 (9), 2358-2363, 2020 | 121 | 2020 |
| The effect of oral supplementation with V Ojetti, G Gigante, M Gabrielli, ME Ainora, A Mannocci, EC Lauritano, ... European review for medical and pharmacological sciences 14, 163-70, 2010 | 113 | 2010 |
| Rifaximin pharmacology and clinical implications V Ojetti, EC Lauritano, F Barbaro, A Migneco, ME Ainora, L Fontana, ... Expert Opinion on Drug Metabolism & Toxicology 5 (6), 675-682, 2009 | 97 | 2009 |
| Early prediction of response to sorafenib in patients with advanced hepatocellular carcinoma: the role of dynamic contrast enhanced ultrasound MA Zocco, M Garcovich, A Lupascu, E Di Stasio, D Roccarina, ... Journal of hepatology 59 (5), 1014-1021, 2013 | 88 | 2013 |
| Predicting in‐hospital mortality in COVID‐19 older patients with specifically developed scores M Covino, G De Matteis, ML Burzo, A Russo, E Forte, A Carnicelli, ... Journal of the American Geriatrics Society 69 (1), 37-43, 2021 | 87 | 2021 |
| Portal vein thrombosis in cirrhosis: Why a well-known complication is still matter of debate M Faccia, ME Ainora, FR Ponziani, L Riccardi, M Garcovich, A Gasbarrini, ... World Journal of Gastroenterology 25 (31), 4437, 2019 | 86 | 2019 |
| Assessment of neurological manifestations in hospitalized patients with COVID‐19 M Luigetti, R Iorio, AR Bentivoglio, L Tricoli, V Riso, J Marotta, C Piano, ... European journal of neurology 27 (11), 2322-2328, 2020 | 53 | 2020 |
| COVID-19 and intestinal inflammation: Role of fecal calprotectin V Ojetti, A Saviano, M Covino, N Acampora, E Troiani, F Franceschi, ... Digestive and Liver Disease 52 (11), 1231-1233, 2020 | 52 | 2020 |
| Microflora imbalance and gastrointestinal diseases V Ojetti, G Gigante, ME Ainora, F Fiore, F Barbaro, A Gasbarrini Digestive and Liver Disease Supplements 3 (2), 35-39, 2009 | 52 | 2009 |
| Diagnosis of bowel diseases: the role of imaging and ultrasonography D Roccarina, M Garcovich, ME Ainora, G Caracciolo, F Ponziani, ... World Journal of Gastroenterology: WJG 19 (14), 2144, 2013 | 47 | 2013 |
| Use of imaging techniques for non-invasive assessment in the diagnosis and staging of non-alcoholic fatty liver disease L Miele, MA Zocco, F Pizzolante, N De Matthaeis, ME Ainora, A Liguori, ... Metabolism 112, 154355, 2020 | 33 | 2020 |
| Usefulness of contrast-enhanced ultrasound (CEUS) in Inflammatory Bowel Disease (IBD) S Pecere, G Holleran, ME Ainora, M Garcovich, F Scaldaferri, ... Digestive and Liver Disease 50 (8), 761-767, 2018 | 32 | 2018 |
| Contrast-enhanced ultrasound for monitoring treatment response in different stages of hepatocellular carcinoma M Faccia, M Garcovich, ME Ainora, L Riccardi, M Pompili, A Gasbarrini, ... Cancers 14 (3), 481, 2022 | 27 | 2022 |
| Usefulness of contrast enhanced ultrasound in monitoring therapeutic response after hepatocellular carcinoma treatment D Roccarina, M Garcovich, ME Ainora, L Riccardi, M Pompili, A Gasbarrini, ... World Journal of Hepatology 7 (14), 1866, 2015 | 27 | 2015 |
| Contrast-enhanced ultrasound patterns of hepatocellular adenoma: an Italian multicenter experience M Garcovich, M Faccia, F Meloni, E Bertolini, I de Sio, G Calabria, ... Journal of Ultrasound 22, 157-165, 2019 | 23 | 2019 |
Antonio GasbarriniProfessor of Gastroenterology, Catholic University, Gemelli Hospital, Rome, Italy在 iol.it 的电子邮件经过验证
